If so, you may have a possible legal case against the manufacturer of the potentially dangerous drug or medical product. Simply fill out the short form below and an experienced legal expert will contact you as soon as possible!

First Name:

Last Name:

Street Address:

City:

State:

Zip:

Daytime Phone Number:

Alternate Phone Number (Optional):

E-Mail Address:

Is this request for you or someone else?
Myself
My Spouse or
Minor Child
Other Relative or Friend

Drug Or Device Exposed To:

Dates Taken:

Related Health Problems Caused By The Drug:

By Clicking Above You Are Agreeing To Our Privacy Policy

March 2005

(03-01-05) March 1st, 2005 | Concerns Over Stevens-Johnson Syndrome Ignorance
Following the recent three day meeting held with the FDA advisory panel, concerns have been raised that the meeting dealt mainly with the heart related risks of cox-2 inhibitors, and not other potentially deadly risks, such as the skin disease Stevens-Johnson Syndrome.

(03-02-05) March 2nd, 2005 | Vioxx Gets Green Light To Come Back On Market
The drug that was at the center of a major scandal last year, and was subsequently withdrawn from the market, has been given the go ahead to make a comeback. Vioxx, a drug manufactured by pharmaceutical giant, Merck, was recalled from the market last autumn following evidence that it was linked to increased risk of heart attacks and strokes.

(03-03-05) March 3rd, 2005 | Studies Show That Painkiller Industry “A Mess”
Studies have shown that the scandal and controversy over various cox-2 inhibitor painkillers last year has left the painkiller industry in something of a mess.

(03-04-05) March 4th, 2005 | Cox-2 Patients Wanted Freedom To Choose
Following three days of meetings, it has been revealed that before and during the meetings some cox-2 patients were urging officials to let them make their own minds up about whether or not to take the drug, despite potentially deadly side effects.

(03-07-05) March 7th, 2005 | Scandal over FDA advisory group
Concerns have been raised over the Food and Drug Administration advisory panel that recently deemed Merck’s Vioxx to be placed back on the market, joining two other controversial drugs that have been allowed to remain on sale, Bextra and Celebrex.

(03-08-05) March 8th, 2005 | Patients Determined To Continue With Cox-2 Drugs
Following the scandal relating to cox-2 inhibitors over the past six or seven months, it has been revealed that many cox-2 users are determined to continue using drugs such as Vioxx, Bextra, and Celebrex, despite the warnings and the restricted access placed on these drugs by the FDA.

(03-09-05) March 9th, 2005 | Ephedra Products Seized
A company in Oakmont has been quizzed by the Food and Drug Administration after the seizure of $13,500 worth of supplements containing the banned ingredient Ephedra.

(03-10-05) March 10th, 2005 | Concerns Over OxyContin Abuse
There are growing concerns over the abuse of the painkilling drug OxyContin, with reports that abuse of this drug and criminal activity linked to its use are on the rise all over the country.

(03-11-05) March 11th, 2005 | Lawsuits Over Prempro And Other HRT Drugs
Hundreds of women across the nation are already taking legal action against the side effects caused by hormone replacement drugs; side effects such as blood clotting and cancer.

(03-14-05) March 14th, 2005 | Schwarzenegger Takes A Stand For Supplements
Following last year’s ban on Ephedra, a weight loss supplement that has been linked to heart attacks, strokes, and deaths, Governor Arnold Schwarzenegger has stated that the FDA should steer clear of trying to enforce regulations on supplements.

(03-15-05) March 15th, 2005 | Cox-2 Drugs Lose Appeal For Americans
A nationwide poll has indicated that a huge number of Americans have abandoned the use of Cox-2 drugs such as Bextra and Vioxx following last year’s controversy over the side effects and potentially deadly harm caused by these drugs.

(03-16-05) March 16th, 2005 | FDA Warning Over Asians Taking Crestor
Crestor is a drug that comes under the umbrella of ‘statins’ and is prescribed for cholesterol reduction.

(03-17-05) March 17th, 2005 | Merck And Pfizer Slammed For Hosting ‘Coke And Pepsi’ Style Marketing
Recent reports in the New York Times have slammed drug manufacturing giants, Merck and Pfizer, for running a ‘Coke and Pepsi’ style marketing campaign, which was all about trying to outdo one another in the popularity stakes rather than trying to keep patients informed and safe from potential side effects of the drugs being marketed.

(03-18-05) March 18th, 2005 | Prempro Risk Of Incontinence
Also known as Premarin, this drug is taken by several million women in the United States on a daily basis. Not all women have to take HRT, as menopause does not affect all women in the same way.

(03-21-05) March 21st, 2005 | Vioxx Death Rates Higher Than Initially Thought
Following the controversy with Cox-2 inhibitor, Vioxx, last year, a new report was published earlier this year indicating that the death rate from the drug could be even higher than initially thought.

(03-22-05) March 22nd, 2005 | Ativan Students Hospitalized
A group of young teenage students at Clippert Multicultural Magnet Academy, southwest Detroit, have been hospitalized after a 13-year-old brought his Ativan pills to the school and shared them with his friends.

(03-23-05) March 23rd, 2005 | FDA Expected To Issue Advisory On Meridia
The weight loss drug Meridia has been at the center of controversy due to potentially dangerous side effects that have been linked to the following studies.

(03-24-05) March 24th, 2005 | FDA Slated For Inadequate Monitoring Of Drugs
A study performed by the government in the United States has revealed that two-thirds of the scientists that actually work for the FDA are not confident that the agency monitors and evaluates the safety of drugs adequately.

(03-25-05) March 25th, 2005 | Merck’s Insurers Want To Walk Away
Since research revealed that Vioxx, a cox-2 inhibitor drug, increased the risks of heart attacks and strokes and was responsible for a number of illnesses and deaths in the past, the manufacturer of the drug, Merck, has been hit with a number of huge lawsuits.

(03-28-05) March 28th, 2005 | Merck Risks Were Not Made Available To All Countries
It has been revealed following a recent study that residents of Puerto Rico were not adequately informed about the dangers of Vioxx by Merck.

(03-29-05) March 29th, 2005 | Student Charged For Oxycontin Distribution
An 18-year-old Catholic student at Greensburg Central Catholic High School has been arrested after taking and distributing Oxycontin pills at the school.

(03-30-05) March 30th, 2005 | FDA States Crestor Is Safe
Following recent controversy, the FDA has released a report that states that Crestor is safe to take providing it is taken properly.

(03-21-05) March 31st, 2005 | FDA Deciding Upon Weight Loss Drug Labelling
Meridia, manufactured by Abbot Laboratories, was approved as the new wonder pill for weight loss shortly after another diet pill, Fen-Phen, had been recalled from the US market due to the dangerous side effects connected to it.

(03-31-05) March 31st, 2005 | FDA Deciding Upon Weight Loss Drug Labelling
Meridia, manufactured by Abbot Laboratories, was approved as the new wonder pill for weight loss shortly after another diet pill, Fen-Phen, had been recalled from the US market due to the dangerous side effects connected to it.